NCT06255808

Brief Summary

The accuracy of breast examinations and ultrasonography performed clinically to detect breast mass varies greatly depending on the physician\'s skill level, and the accuracy of breast examinations by non-experts is particularly low. In this study, we aimed to validate whether the concurrent use of ultrasound sensor technology is an efficient strategy for the purpose of improving the sensitivity of detecting breast masses through breast examination.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 4, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 13, 2024

Completed
8 months until next milestone

Study Start

First participant enrolled

October 5, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2025

Completed
Last Updated

December 4, 2024

Status Verified

December 1, 2024

Enrollment Period

5 months

First QC Date

February 4, 2024

Last Update Submit

December 3, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Device performance

    Sensitivity/specificity/predictive value/accuracy/positive predictive value/ negative predictive value of diagnostic performance

    Within 1 year after the study participant registration deadline

Secondary Outcomes (1)

  • Artificial intelligence algorithm efficacy

    Within 2 year after the study participant registration deadline

Study Arms (1)

Ultrasonic group

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

scheduled for surgery after a tumor has been confirmed on breast ultrasound examination

You may qualify if:

  • female patients between 18 and 80 years of age who are scheduled for surgery after a tumor has been confirmed on breast ultrasound examination

You may not qualify if:

  • Patients diagnosed with breast cancer after biopsy with non-mass enhancement or calcification
  • Inflammatory breast cancer
  • Patients whose cancer has invaded the skin and broken through
  • Patients with skin diseases
  • Women who refused to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 03080, South Korea

Location

MeSH Terms

Conditions

Breast NeoplasmsCystic Fibrosis

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professior

Study Record Dates

First Submitted

February 4, 2024

First Posted

February 13, 2024

Study Start

October 5, 2024

Primary Completion

February 27, 2025

Study Completion

April 5, 2025

Last Updated

December 4, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations